Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Examining Developmental Outcomes of Children Diagnosed With CLN2 Disease

NCT03862274 is registered in ClinicalTrials.gov with Jessica Scherr as lead sponsor.

NCT NCT03862274
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03862274 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Examining Developmental Outcomes of Children Diagnosed With CLN2 Disease
Lead sponsor
Jessica Scherr
Phase
Observational
Overall status
Enrolling by invitation
Start date
December 1, 2018
Completion date
December 31, 2025
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

batten disease, cln2, neuronal ceroid-lipofuscinoses